An approximately ¥4 billion investment project to expand the existing amino acid manufacturing, raw material, separation, drying and packaging facilities, as well as the cleanroom, at the Tokiwa Plant in response to growing demand for glycine. The group covers progress on the capital investment through completion in June 2025.